Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica

Page 1 of about 1 results

ea0099p163 | Thyroid | ECE2024

The effect of monoclonal antibodies alemtuzumab and ocrelizumab on the thyroid function of patients with multiple sclerosis

Kazakou Paraskevi , G Vakrakou Aigli , Tzanetakos Dimitrios , S Tzartos John , Anagnostouli Maria , Stathopoulos Panos , Dermentzoglou Alexandros , N Kassi Georgia , Kilidireas Constantinos , Zapanti Evangelia

Aim: Autoimmune thyroid disease (AITD) is the most common adverse effect in alemtuzumab (ALZ) treated relapsing–remitting (RR) multiple sclerosis (MS) patients. The objective of this prospective study was to analyze the occurrence, timing of onset, clinical course, and laboratory characteristics of AITD post-ALZ and subsequently the clinical outcome of AITD post-ALZ in patients who received ocrelizumab.Patients and methods: We evaluated 36 RRMS pati...
0 shares

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more